Table 3.
Characteristic | Associations with depression prevalence – odds ratios (95% CI) displayed for simultaneously entered covariates
|
||||
---|---|---|---|---|---|
Unadjusted | Adjusted model 1a | Adjusted model 2b | Adjusted model 3c | Final model 4d | |
Age, years | 0.96 (0.92–1.01) | 0.96 (0.92–1.01) | 0.98 (0.92–1.05) | 0.98 (0.92–1.05) | 0.96 (0.91–1.01)+ |
Psychosocial factors | |||||
Insomnia (yes/no) | 2.95 (1.26–6.92)* | 2.38 (0.97–5.89)+ | 2.22 (0.87–5.65)+ | 2.44 (0.94–6.36)+ | 2.01 (0.78–5.15) |
Psychiatric family history (yes/no) | 3.81 (1.37–10.6)* | 2.13 (0.71–6.43) | – | – | – |
Pain severity (score) | 1.29 (1.11–1.50)** | 1.25 (1.07–1.47)** | 1.32 (1.12–1.57)** | 1.32 (1.11–1.56)** | 1.27 (1.08–1.49)** |
Cancer-related factors | |||||
Menopause (yes/no) | 0.41 (0.18–0.94)* | – | 0.50 (0.15–1.67) | 0.43 (0.12–1.52) | – |
Duration of breast cancer (years) | 0.31 (0.12–0.84)* | – | 0.31 (0.11–0.89)* | 0.45 (0.15–1.40) | – |
Treatment | |||||
Radiation therapy (yes/no) | 3.05 (1.11–8.37)* | – | – | 4.61 (1.40–15.1)* | 5.53 (1.69–18.06)** |
Hormone therapy (yes/no) | 0.43 (0.19–0.98)* | – | – | 0.32 (0.11–0.93)* | 0.23 (0.08–0.62)** |
Family support (score) | 0.84 (0.75–0.93)*** | – | – | – | 0.87 (0.78–0.98)* |
Notes:
Adjusted for age, insomnia, psychiatric family history, and pain severity;
Adjusted for age, insomnia, pain severity, menopause (yes/no), and duration of breast cancer (years);
Adjusted for age, insomnia, pain severity, menopause (yes/no), duration of breast cancer (years), radiation therapy (yes/no), and hormone therapy (yes/no);
Adjusted for age, insomnia, pain severity, radiation therapy (yes/no), hormone therapy (yes/no), and family support. Statistically significant
0.05<p<0.10,
p<0.05,
p<0.01,
p<0.001. ‘–’, variables were not included in multiple logistic regression.